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Abstract:
Chronic tendinopathy is characterized with longstanding activity-related pain with
degenerative tendon injuries. An objective tool to measure painful responses in animal 
models is essential for the development of effective treatment for tendinopathy. Gait 
analysis has been developed to monitor the inflammatory pain in small animals. We 
reported the use of motion analysis to monitor gait changes in a rat model of 
degenerative tendon injury. Intratendinous injection of collagenase into the left 
patellar tendon of Sprague Dawley rat was used to induce degenerative tendon injury, 
while an equal volume of saline was injected in the control groups. Motion analyses 
with a high-speed video camera were performed on all rats at pre-injury, 2, 4, 8, 12 or 
16 weeks post injection. In the end-point study, the rats were sacrificed to obtain 
tendon samples for histological examination after motion analyses. In the follow-up 
study, repeated motion analyses were performed on another group of 
collagenase-treated and saline-treated rats. The results showed that rats with injured 
patellar tendon exhibited altered walking gait as compared to the controls. The change 
in double stance duration in the collagenase-treated rats was reversible by 
administration of buprenorphrine (p = 0.029), it suggested that the detected gait 
changes were associated pain. Comparisons of end-point and follow-up studies 
revealed the confounding effects of training, which led to higher gait velocities and 
probably a different adaptive response to tendon pain in the trained rats. The results 
* Manuscript (With Page Numbers)
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showed that motion analysis could be used to measure activity-related chronic tendon 
pain. (Word count: 247)
Keywords: motion analysis, tendon pain, patellar tendon, gait, tendinopathy
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Introduction:
Chronic tendinopathy refers to insidious onset of chronic activity-related pain that can 
affect virtually all tendons. The pathogenesis of chronic tendinopathy remains
speculative (Riley, 2004). It is generally regarded as a result of failed healing to 
accumulated micro-injuries (Khan, 1999). Treatments are empirical and 
symptom-based, and the responses to treatment vary a lot (Alfredson, 2005). Previous 
experimental studies on chronic tendinopathy included analyses of clinical samples of 
tendinopathic tissues (Fu, 2002; Fu, 2007; Fu, 2002; Rolf 2001) Histopathological 
changes similar to those in clinical samples of tendinopathy were reproduced in 
animal models by overuse (Glazebrook, 2008), injection of collagenase (Chen, 2004)
or cytokines (Stone, 1999). However, owing to a lack of measurement of pain, 
representative animal models for chronic tendinopathy could not be established.
Breakthroughs for experimental studies for chronic tendinopathy will reside on the 
development of an objective measure of tendon pain in animal models.
A number of methods were developed to measure pain in small animals, including 
measurement of weight-bearing (Vrinten, 2003), mechanical sensitivity (Fernihough, 
2004), vocalization (Han, 2005) and gait analysis such as footprint analysis (Marxen, 
2004) and motion analysis [Coulthard, 2002; Coulthard, 2003; Varejao 2002]. As 
chronic tendinopathy is characterized with activity-related pain, it is more plausible to 
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detect the pain-associated changes in dynamic state (walking) instead of static state 
(standing). Gait analysis has been developed to monitor inflammatory pain in small 
animals, such as rats (Coulthard, 2003), as well as large animals such as horse 
(Marxen, 2004). Coulthard P (2002; 2003) demonstrated the use of motion analysis as 
a reproducible, objective measure for acute and chronic pain induced with intraplantar 
injection of irritants, characterized by significant changes in temporal gait parameters
such as double stance duration. Changes in ankle angle during stance phase have been 
used to investigate functional recovery in rats (Varejao, 2002). Knee joint pain 
induced by arthritis was widely studied in animal model by motion analysis
(Neugebauer, 2007), but it is still unexplored if pain associated with degenerative 
patellar tendon injury could be monitored by the same technique.
In the current study, we reported th  use of motion analysis of the saggital plane of 
walking gait to measure painful responses in a rat model of collagenase-induced 
degenerative tendon injury. Several unexplored areas in measurement of 
pain-associated gait changes were addressed. Firstly, changes in the contralateral side 
of the injured limb were analyzed in order to evaluate if there was compensatory 
change in the contralateral side. Secondly, two different double stance durations 
within a stride were separately measured. Double stance duration (DS) is defined the 
duration when both limbs touch the ground during a stride. It follows that two 
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separate DS are identified in a stride: one ended with the take-off of the contralateral 
limb, while another ended with the take-off of the observed limb. However, there was 
no clear distinction between the two in previous reports (Coulthard, 2002; Coulthard, 
2003). Since DS is identified as a sensitive parameter to characterize pain (Simjee, 
2004), it is necessary to distinguish the two for the use of DS as a valid measurement 
for pain. Thirdly, the influences of repeated measurements as training effect were 
evaluated when comparing the results of follow-up study with those of end-point 
measurement.
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Materials and Methods:
The procedures in the following animal experiments were approved by the Animal 
Research Ethics Committee, the Chinese University of Hong Kong. 
Experimental design
Fifty-eight male Sprague Dawley rats, at an age of eight weeks, weighting 250-300 
grams, were used in this study. In the end point study, forty-two rats were randomly 
assigned into different groups. Six rats were subject to motion analysis without 
injection to the knee as pre-injection group. Thirty rats were assigned to receive
collagenase injection and subject to motion analysis at 2, 4, 8, 12 and 16 weeks post 
injection (n=6). Six rats received saline injection as control and motion analysis was 
performed at 16 weeks post injection. These rats were sacrificed immediately after 
motion analysis. Patellar tendon samples were obtained for histological examination. 
In the follow-up study, sixteen rats were randomly assigned into the collagenase 
group (n = 8) and the saline group (n=8). Motion analysis was performed before the 
injection, at 2, 4, 8, 12 and 16 weeks post-injection. At 18 weeks post injury, both 
groups of rats received one intraperitoneal injection of buprenorphrine (0.25 mg/kg 
body weight). Motion analysis was performed at 30 minutes and 28 hours after 
buprenorphrine administration, according to the pharmacological actions of 
buprenorphrine as analgesics.
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Collagenase-induced degenerative tendon injury
Collagenase I (bacterial collagenase type I; Sigma Chemical Inc.) was reconstituted in 
0.9 % saline and filtered with a 0.22μm syringe filter (Millipore) for sterilization. A 
20ul aliquot of 0.3mg collagenase I or saline was intratendinously injected (Chen, 
2004) to the left patellar tendon, and the injection was monitored with high resolution
ultrasound imaging (Visualsonics, Toronto, Canada). Free cage activity was allowed
after injection. The body weight of the rats was measured regularly during the study. 
Motion analysis
Gait recording was performed at the time points aforementioned with a similar set-up 
described by Messner (1999). At each time point, each rat was encouraged to walk in 
a 1.5-meter straight enclosed walkway with darkened ends. The walkway was made 
with transparent plastic to allow videotaping the rat motion from outside (Figure 1A). 
One day before data collection, the hair on rear body of each rat was shaved to expose 
the major joint positions under anaesthesia by intraperitoneal injection of 2.5% (w/v) 
sodium pentobarbital (45 mg/kg body weight). Hip, knee, ankle and toe were marked 
with black ink on both hind limbs and checked for the consistency of marks and joint 
movement (Figure 1B). One CCD digital video camera (JVC 9600, Japan) with a 
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100-Hz filming rate at a 1/250s shutter speed was used to videotape the rat motion in 
the saggital plane. Video data were collected by placing each rat in one end of the 
walkway and allowing ambulation across the central part of the walkway (Figure 1C). 
A reference point was also marked on the central part of the walkway for the 
calculation of gait velocity (Figure 1E) and stride length with a calibration with a ruler 
placed on the walkway. Each rat walked in both directions along the track in order to 
record the gait in both limbs. When three consecutive strides with stable speed were 
performed, the middle stride was identified as a successful stride trial. Four successful 
trials were collected for each side from each rat, and the trials with median gait 
velocity were taken for further analysis.
The video data was processed by a motion analysis system (Ariel Performance 
Analysis System, USA). The video of each successful trial was trimmed from the time 
of foot strike to the time of the next foot strike of the observed limb, as identified 
visually from the video. The time of take-off after the first foot strike was also 
visually identified and thus the stride duration, stride length, stance duration and
swing duration were measured. In addition, the time of take-off of the contralateral 
limb was also visually identified to determine the double stance duration (DS), and 
this DS was registered as a measurement for the observed limb. For example, double 
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stance duration ended with take-off of control side (DS-C) was measured in the video 
records of the injection side, while the double stance duration ended with the take-off 
of the injection (DS-I) was measured in the video records of the control side. For the 
analysis of knee motions, each frame in each trial was digitized to obtain 2-D 
coordinates of the markers. The knee angles were obtained and time-normalized to 
0-100% stance and 0-100% swing (Figure 1D). The average knee angular velocities at 
mid-stance (KVMS) and mid-swing (KVMW) was calculated as the rate of change in 
the angular displacement of knee joint at 40-60 % stance and 40-60 % swing 
respectively.
Histological examination
In the end-point study, the rats were euthanized with an overdose of sodium 
pentobarbital (25 % w/v) immediately after motion analysis. The patellar tendons
were harvested to prepared histological sections. The specimens were fixed in 10% 
buffered formalin overnight and paraffin-embedded for haematoxylin and eosin 
staining.
Statistical analysis
SPSS software version 15.0 (SPSS Inc., Chicago, IL) were used for all statistical tests. 
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Statistical significance was accepted at α = 0.05. All data were checked with normal 
distribution by Kolmogorov-Smirov test. For the end-point study, a multivariate 
analysis of variances (MANOVA) was used to detect significant differences with gait 
velocity, stride length, stride duration, stance duration, swing duraiton, double stance 
duration, average knee angular velocity at mid-stance and mid-swing as outcome 
variables. The effects of treatment (collagenase vs. saline injection) and time post 
injection were determined, as well as the interaction between treatment and side of 
injection, and the interaction between treatment and time post injection. For the 
follow-up study, a design of analysis of variances (ANOVA) with repeated measure
was used to analyze the effects of collagenase injecton (collagenase vs saline) as 
between-subjects factor, the effects of time after injection (6 levels: pre-injection, 2, 4 
8, 12 and 16 weeks post injection) and side of injection (2 levels: injected side and 
control side) as within-subject factors. The same group of gait parameters were 
entered into the ANOVA model as dependent variables. For the study of the effect of 
analgesic, ANOVA with repeated measure was used with collagenase injecton 
(collagenase vs saline) as between-subjects factor and time after injection of 
buprenorphrine was within-subject factor (3 levels: before injection of buprenorphrine, 
30 min and 28 hours after buprenorphrine injection). 
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Results:
Histology
Extensive matrix degradation and increased healing tendon cells were noticed with 
inflammatory response at week 2 post collagenase injection (Figure 2A). The 
cellularity slightly decreased in week 4 (Figure 2B) and week 8 (Figure 2C) with 
limited healing responses; but further matrix disturbance was developed in the 
absence of inflammatory cells at week 12 (Figure 2D). At 16 weeks after injection, 
tendon degeneration was observed in the collagenase groups with increased cellularity, 
increased vascularity and significant matrix disturbance with calcification (Figure 2E), 
while normal tendon histology was found in the group with saline injection (Figure 
2F).
End-point study
The statistical results for the gait analyses of the end-point and follow-up study were
presented in Table 1. Significant changes in gait velocity (p=0.001) with time were
detected, but the difference between the collagenase-treated and the saline-treated rats
was not significant (p =0.134) (Figure 3A). Significant decrease in stride length
(p<0.001) and swing duration (p<0.001) were detected in collagenase-treated rats as 
compared to the saline-treated rats (Figure 3B, C). Double stance duration ended with 
take-off of control side (DS-C) was significantly increased in the collagenase-treated 
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rats (p=0.038) (Figure 3D). Average knee angular velocity at mid swing (KVMW) in 
the contralateral side of the collagenase-treated rats was higher than that in the 
saline-treated rats at 16 weeks post injection (p=0.008) (Figure 3E). Average knee 
angular velocity at mid stance (KVMS) did not show significant difference between 
collagenase and control group (p = 0.897) (Figure 3F), but a marginally significant 
interaction between treatment and side of injection was detected (p = 0.048). As we 
only collected saline-treated groups at 16 weeks post injection, the between-subject 
effect of Treatment*Time was not available.
Follow-up study
The body weight of the collagenase-treated rats (545 + 57g) and the saline-treated rats 
(507 + 37g) at 18 weeks post injury exhibited no significant difference (Student’s t 
test, p = 0.15). As compared to the pre-injection levels, both the collagenase-treated 
and the saline-treated rats walked faster (Figure 4A) with increased stride length 
(Figure 4B) but the differences between the two groups were statistically insignificant. 
Decreased swing duration was noticed in the saline-treated rats (p = 0.023) but not in 
the collagenase-treated rats (Figure 4C). Double stance duration and KVMW 
exhibited no significant difference between the collagenase-treated and the 
saline-treated rats (Figure 4D, E). A time-dependent increase in KVMS was observed 
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in the contralateral side of collagenase-treated rats but not in the saline-treated rats
(p=0.003) (Figure 4F). 
Effect of buprenorphrine
Buprenorphrine injection induced a significant restoration in DS-C after 30 min in the 
collagenase-treated rats and the DS-C returned to the original level after 28 hours (p = 
0.029) (Table 1). No significant change in gait parameters was detected in the 
saline-treated control after buprenorphrine injection (Figure 5).
Comparisons of end point study and follow-up study
Except in the pre-injury groups, the gait velocities of the rats in follow-up study were 
significantly higher than those in the end-point study (Student’s t test, p<0.05) (Figure 
6). Significant time-dependent changes were detected in all gait parameters in the 
follow-up study, but only in some gait parameters in the end-point study (Table 1). 
Collagenase-induced tendon injury caused an increased DS-C (Figure 3C) in the 
end-point study, but a decreased DS-C (Figure 4D) was noticed in the follow-up study 
despite statistical significances were not detected (p=0.068).
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Discussion:
We reported the use of motion analysis to measure chronic painful response 
associated with degenerative tendon injuries. It was found that altered walking gait, 
marked by an increase in double stance duration ended with take-off of contralateral 
control side (DS-C), was resulted from a non-healing degenerative tendon injuries 
induced by collagenase injection. The gait change was suppressible by 
buprenorphrine and the analgesic effect could not carry over 24 hours after single 
injection (analgesic effect of buprenorphrine lasts for 8- 10 hours), indicating that a 
painful response was associated with the collagenase-induced tendon injuries. These 
findings supported that the animal model of collagenase-induced tendon injury 
resembled the longstanding pain in chronic tendinopathy. Significant changes in the 
gait parameters of the contralateral limbs in collagenase-treated rats suggested
adaptive motions to reduce mechanical allodynia in the injured limbs. Our results 
indicate that motion analysis was useful for the detection of knee pain associated with 
patellar tendon injuries at longer time points post injury as compared to previous 
studies which worked on relatively short-term inflammatory pain (Coulthard, 2003), 
Achilles tendon injuries (Messner, 1999) or arthritic knee (Simjee 2004).
Histological examination revealed that collagenase treatment induced matrix damage 
and healing response in early time points (2 and 4 weeks). However, the healing 
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responses failed to restore normal tendon histology after 8 weeks post injury, with 
persistent matrix disturbance including loss of collagen birefringence and appearance 
of tendon calcification (Lui, 2008). On the other hand, saline injection did not cause
observable injury in patellar tendons up to 16 weeks post injury. The time frame of the 
present study encompassed the inflammatory phase of the primary injury, the healing 
response and the development of failed healing outcomes. As compared to previous 
studies of short-term follow up of gait changes which might only cover the 
inflammatory phase (Coulthard, 2003), the temporal gait changes within 16 weeks 
post injury appeared more complicated. Though it is difficult to correlate the local 
histopathological changes in the injured patellar tendon to the overall changes in gait 
parameters, the injury or healing status in relation to pain level may contribute to the 
variations in the walking gait of the rats.
In the end-point study, the gait change was primarily the lengthened double stance 
duration (DS) in the collagenase-treated rats, which might be due to a delayed take-off 
especially in the contralateral control limb. Delayed take-off may shorten swing 
duration as KVMW was also increased, and shortened swing duration would probably
affect the stride length, which was also found to be shorter in the collagenase rats. 
These findings suggested that various gait parameters are coherent entities which 
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affect one another. The observed increase in DS as an indicator of pain was consistent 
to previous reports on inflammatory pain (Coulthard, 2002; Coulthard, 2003; Simjee 
2004), which was explained as an adaptive mechanism to reduce mechanical agitation 
to the injured limb to avoid pain.
In the follow-up study, the differences between collagenase-treated rats and saline 
controls were less obvious. Relatively longer swing duration and a decrease in DS-C 
were observed in the collagenase-treated rats, which was just opposite to the findings 
in the end-point study. Comparing the results in both studies, it was found that the gait 
velocities of collagenase-treated rats were significantly higher in the follow-up study 
(Figure 6). It is probably due to the training effect on the rats to walk along the track, 
as all rats in the follow-up study received repeated motion analysis while rats in the 
end-point study only received once. Since DS exhibited an inverse relationship to gait 
velocity (Figure 7A), fast walking rats naturally shortened DS, which did not favor
the strategy of pain avoidance by increasing the DS in high speed walking. In order to 
determine if gait velocity affected the pain-associated change as shown in DS, 
standardization of DS was performed to remove the influences of gait velocity 
according to van Iersel MB (2007). In brief, a linear regression was performed 
between DS and the inverse of gait velocity, and the regressed values of DS were 
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calculated from gait velocity in each trial, which represented the average DS at the 
specified gait velocity (Figure 7B). Residual DS was calculated by subtracting the 
regressed DS from the observed DS, which represented the deviations from the 
average DS at the specified gait velocity, and the influence of gait velocity on DS was 
removed (Figure 7C). It was found that the velocity-standardized DS (residual DS) in 
the collagenase-treated rats was still higher in the end-point study and lower in 
follow-up study as compared to the saline control (Figure 7D). It suggests that gait 
velocities did not directly affect the direction of pain-associated changes in DS. 
Different strategies for adaptation of degenerative tendon injuries might be employed 
in the rats during high speed walking and low speed walking. Since KVMS in the 
collagenase-treated rats was higher in the contralateral control limb in the follow-up 
study (Figure 4F) and lower in the injected limb in the end-point study (Figure 3F), it 
is speculated that during high speed walking the rats avoided mechanical agitation on 
the injured limb by a faster motion in the contralateral control limb; while at low 
speed walking the rats could simply decelerate the motion of the injured limb. It 
follows that gait velocity would confound the use of DS as a measurement of painful 
responses. As repeated motion analyses might train up the rats to complete the task 
faster (higher gait velocity), end-point measurement is preferable with a lower gait
velocity and greater variability to detect difference. Moreover, exclusion criteria 
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according to gait velocity could be applied to restrict data collection of moderate 
voluntary walk to enable consistent measurement of pain-associated gait changes.
There are several limitations in the present study. Firstly, collagenase-induced 
degenerative tendon injuries may not fully represent tendinopathy; despite there is a 
long history of the use of collagenase model to study tendinopathy (William, 1984). Other 
models are established to address different aspects in the development of degenerative 
injuries, including the injection of cytokines (Stone, 1999), prostaglandins (Khan,
2005) and application of long-term overuse exercise (Glazebrook, 2008). Due to 
unknown pathogenesis, these established models for tendinopathy could only 
reproduce similar histopathological features of tendinopathy at advanced stage, as 
clinical samples of tendinopathy wer  obtained from patients resistant to conservative 
treatments. Thus the measurement of tendon pain in animals is crucial to complement 
the histopathological findings in these models, as chronic tendon pain is the key 
feature of clinical cases of tendinopathy. Further works could apply motion analysis to 
detect painful responses in other tendinopathy animal models in order to collect more 
information about histopathological changes and pain in tendinopathy.
The second limitation is the skin movement of the rats which may decrease the 
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accuracy in the measurement of knee angles (Filipe, 2006). Strictly speaking, it is 
almost impossible to determine the exact position of the knee by marking the skin 
over the knee. However, marking on the skin over the joints may still convey some 
information about joint motion, for example, we could still identify when the knee 
joint flex or extend, that is probably why external marker over skin is still used in 
many kinematic studies. In our study, the marking over the joints had been carefully 
checked by flexing the knee and the ankle, and these markings consistently revealed a 
general pattern of knee motion during walking, as demonstrated in the plot of angular 
displacement against time (Figure 1D). Unsatisfactory marking could be identified as 
significant deviations from normal knee motion in the kinematic plot.
The third limitation is about the difficulties to include kinematic data at the ankle joint 
for a better data interpretation. It is possible that knee pain associated with patellar 
tendon injury also would affect the ankle motion as compensatory motion, but it is too 
complicated to include ankle data in the present study. As it is a general practice to 
report many inter-related gait parameters in order to have a comprehensive description 
of the animal gait, multiple comparisons are unavoidable which may lead to increased 
chance of Type I error. Analysis of ankle data would further increase number of
comparisons on the same set of data. Previous studies on animal gait (Coulthard, 2002; 
Coulthard, 2003; Simjee 2004) also faced the same problem of multiple comparisons, 
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but adjustments were made only to multiple 2-group comparisons. In our study, we 
analyzed the data with MANOVA and ANOVA with repeated measures but post hoc 
multiple group comparisons were not performed.
Finally, the loading force on the injured limb was not measured in this study, which 
may provide new information about the avoidance of mechanical loading on the 
injured limb.
In conclusion, motion analysis is applicable to measurement of painful responses 
associated with degenerative tendon injuries in rat models, but the gait velocity of the 
rats should be carefully controlled to optimize the measurement.
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Figure legends
Table 1
Statistical results for the motion analyses
Multivariate analysis of variances (MANOVA) was used to analyze data in the 
end-point study, while analysis of variances (ANOVA) with repeated measure was 
used in the follow-up study and the analgesic study. * marks statistical significance at 
 = 0.05. N.D. represents “Not Determined”.
Figure 1
Experimental set-up of motion analysis on the walking gait of rats
The rats were encouraged to walk through a transparent walkway (A) during motion 
analysis. The video camera was positioned to capture the rat motion in the saggital 
plane as shown in the diagram (B). Both hind limbs of the rats were marked on the 
joints of hip, knee, ankle and toe and checked for consistency of marks and joint 
movement by moving the limbs, as shown by a consistent kinematic plot for knee 
angle during a stride (C). With the help of the reference point and the marks on the 
joints, the gait parameters and knee angles were measured by a motion analysis 
system (D).
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Figure 2
Histology of collagenase-induced injury in patellar tendon samples
Intratendinous injection of collagenase induced significant tissue damages and 
increased cellularity including inflammatory cells and healing tendon cells were
observed in the injured tendons at 2 weeks post injection (A). The cellularity slightly 
decreased in week 4 (B) and week 8 (C) with limited healing responses. Matrix 
disturbance was developed in the absence of inflammatory cells at week 12 (D). At 16 
weeks after injection, tendon degeneration was observed in the collagenase groups 
with increased cellularity, increased vascularity and significant matrix disturbance 
with calcification (E), while normal tendon histology was found in the group with 
saline injection (F). (optical magnification: 100X)
Figure 3
Results of motion analysis of the end-point study on collagenase-induced patellar
tendon injury
The significant effects of collagenase-induced patellar tendon injury were shown on 
various gait parameters including gait velocity (A), stride length (B), swing duration 
(C), double stance duration (D), and average knee angular velocity at mid-swing 
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(KVMW) (E) and at mid-stance (KVMS) (F). Statistical analysis was performed by 
multivariate analysis of variances (MANOVA) and the detailed results were shown in 
Table 1.
Figure 4
Results of motion analysis of the follow-up study on collagenase-induced patellar
tendon injury
The results of the follow-up study were shown on the same set of gait parameters in 
the endpoint study. These gait parameters include gait velocity (A), stride length (B), 
swing duration (C), double stance duration (D), and average knee angular velocity at 
mid-swing (KVMW) (E) and at mid-stance (KVMS) (F). As repeated measurements 
for individual rats were made, thes  gait parameters were expressed as differences 
relative to pre-injection level. Statistical analysis was performed by analysis of 
variances (ANOVA) with repeated measure and the detailed results were shown in 
Table 1.
Figure 5
Effect of buprenorphrine injection on double stance duration
At 30 min after injection, buprenorphrine induced a significant increase in double 
Page 28 of 37
Ac
ce
pte
d M
an
us
cri
pt
27
stance duration ended with take-off of contralateral control side (DS-C) in the 
collagenase-treated rats but not the saline treated rats. At 28 hours after 
buprenorphrine injection, the DS-C returned to the original level in the 
collagenase-treated rats, and no significant change was detected in the saline-treated 
rats.
Figure 6
Comparison of gait velocities in the collagenase-treated rats in the end-point and 
the follow-up study
Except in the pre-injury groups, the gait velocities of the rats in follow-up study were 
significantly higher than those in the end points study (Student’s t test, p<0.05). * 
marks statistical significance at  = 0.05.
Figure 7
Standardization of double stance duration with gait velocity
A scatter plot revealed an inverse relationship between double stance duration (DS) 
and gait velocity (A). A regression analysis between DS and gait velocity returned the 
regressed values of DS from observed gait velocities (B). Standardization was 
achieved by calculating the residual DS as the difference between regressed DS and 
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observed DS, which represented the deviation from averaged DS at specified gait 
velocity. The influence of gait velocity on DS was thus removed as shown in a plot 
between residual DS and gait velocity (C). A lower velocity-standardized DS (residual 
DS) was noticed in the follow-up study, while a higher residual DS was found in the 
endpoint study (D).
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Table1: Statistical results of gait analyses
End-point study Follow-up study Analgesic study
MANOVA Repeated measure ANOVA
Gait parameter s Between-subjects factor Within-subject factor Between-
subjects factor
Within-subject factor
Time Treatment
^Time
Treatment
^Side
Treatment Time Treatment
^Time
Treatment
^Side
Treatment Analgesic Analgesic
^Treatment
Gait velocity 0.001* N.D. 0.235 0.134 <0.001* 0.085 0.556 0.519 0.004* 0.224
Stride length <0.001* N.D. 0.679 <0.001* <0.001* 0.543 0.896 0.097 0.344 0.453
Stride duration 0.672 N.D. 0.228 0.963 <0.001* 0.162 0.388 0.076 <0.001* 0.214
Stance duration 0.454 N.D. 0.348 0.274 <0.001* 0.087 0.874 0.136 <0.001* 0.210
Swing duration <0.001* N.D. 0.243 <0.001* <0.001* 0.226 0.09 0.023* 0.001* 0.558
Double stance 
duration (DS)
0.008* N.D. 0.614 0.047* <0.001* 0.721 0.068 0.539 0.003* 0.029*
Knee angular
velocity at 
midswing
(KVMW)
<0.001* N.D. 0.019* 0.008* <0.001* 0.948 0.148 0.399 0.019* 0.858
Knee angular
velocity at 
midstance
(KVMS)
0.001* N.D. 0.048* 0.897 0.003* 0.003* 0.568 0.850 0.001* 0.345
Table 1
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